Patient basic information Patient: Ms. Layla Wilson) Nationality: Belarusian Disease Diagnosis: Cerebral vascular atrophy Diagnostic hospital: H 0 0 Treatment plan: Inner lens treatment + medication Inpatient days: 11 days Treatment cost: about 324206 yuan Treatment effect: partial relief The patient is from Belarus, where she was diagnosed with Cerebral vascular atrophy. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process.
After 11 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard. Treatment results: Patient's final part of relief. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient, and continued to track recovery through a remote follow-up system.
'Mrs. Liu Layla Experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases. Liu4 is based on a multidisciplinary collaborative mechanism, which has developed an intracellular treatment + drug program for cerebral vascular atrophy, reflecting the comprehensive strength of Chinese hospitals in the field of diagnostics of suspected diseases, as well as a summary of how international medical services are regulated.
(Figure from Liu5 official news reports and medical scenarios)